Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells... Show more
Industry MedicalNursingServices
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ASVCX | 23.69 | 0.16 | +0.68% |
| American Beacon Small Cp Val C | |||
| GFBLX | 42.74 | 0.01 | +0.02% |
| American Fds Global Balanced F-3 | |||
| ABWIX | 17.35 | N/A | N/A |
| AB All Market Total Return I | |||
| SUPCX | 24.12 | N/A | N/A |
| DWS Equity Sector Strategy Fund Class C | |||
| GRHAX | 23.45 | N/A | N/A |
| Goehring & Rozencwajg Resources Retail | |||
A.I.dvisor indicates that over the last year, CTKB has been loosely correlated with CRL. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CTKB jumps, then CRL could also see price increases.
| Ticker / NAME | Correlation To CTKB | 1D Price Change % | ||
|---|---|---|---|---|
| CTKB | 100% | +1.77% | ||
| CRL - CTKB | 44% Loosely correlated | +1.93% | ||
| RVTY - CTKB | 42% Loosely correlated | +2.79% | ||
| A - CTKB | 39% Loosely correlated | +2.66% | ||
| UTMD - CTKB | 38% Loosely correlated | +0.10% | ||
| TXG - CTKB | 38% Loosely correlated | +3.33% | ||
More | ||||
| Ticker / NAME | Correlation To CTKB | 1D Price Change % |
|---|---|---|
| CTKB | 100% | +1.77% |
| Health Services category (242 stocks) | 10% Poorly correlated | +0.38% |
| Medical/Nursing Services category (141 stocks) | 9% Poorly correlated | +0.38% |
CTKB moved above its 50-day moving average on September 11, 2026 date and that indicates a change from a downward trend to an upward trend. In 32 of 38 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 84%.
The 10-day moving average for CTKB crossed bullishly above the 50-day moving average on August 11, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Following a +1.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where CTKB advanced for three days, in 225 of 288 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The 10-day RSI Indicator for CTKB moved out of overbought territory on August 14, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 20 similar instances where the indicator moved out of overbought territory. In 16 of the 20 cases, the stock moved lower in the following days. This puts the odds of a move lower at 80%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 46 of 54 cases where CTKB's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 85%.
The Momentum Indicator moved below the 0 level on September 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CTKB as a result. In 65 of 73 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
The Moving Average Convergence Divergence Histogram (MACD) for CTKB turned negative on September 01, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 39 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 87%.
CTKB broke above its upper Bollinger Band on August 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. CTKB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 69 (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.859) is normal, around the industry mean (10.685). P/E Ratio (0.000) is within average values for comparable stocks, (67.907). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.653). CTKB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (2.862) is also within normal values, averaging (35.925).
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTKB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.